United States Home Infusion Market, Size, Global Forecast 2023-2027, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
United States Home Infusion Market will reach US$ 20.6 Billion by 2027 according to Renub Research. Home infusion is a clinically suitable treatment option for patients with a wide array of chronic and acute conditions, ranging from bacterial infections to progressively complex conditions like immune deficiencies, nutrition support, bleeding disorders, and late-stage heart failure. Home infusion can afford patients liberty and better quality of life since it is offered in the comfort of the patient's home, effectively fitting their needs. It also gives better outcomes, provides enhanced safety, and is cost-effective.
The increasing geriatric population susceptible to chronic diseases and rising prevalence of urinary tract infections will boost the market growth:
The rapidly growing old-aged population in the United States is one of the main drivers of market growth. For instance, according to data issued by the United States Department of Health and Human Services, there are more than 49.2 million individuals above 65 years of age across the country. Moreover, the number of graying Americans has risen by around 33% over the past decennium. Therefore, as home infusion therapy aids in managing chronic conditions of the elderly populace, the market will witness significant growth in the future.
According to a recent news article, urinary tract infections contribute to about 6 million patient visits to physicians each year in the United States Thus, a large patient pool requiring home infusion therapy will generate high demand over the analyzed period. In addition, the acceptance of new technologies in the home infusion therapy market will support the industry's growth.
United States Home Infusion Market is expected to grow with a CAGR of 7.88% from 2022 to 2027
Amongst other segments, an infusion pump holds a significant share in 2022. This can be attributed to their efficiency and increasing use in delivering medications, nutrition, and other required fluids in required amounts. Needleless connectors is anticipated to be the fastest-growing segment over the forecast period owing to various benefits, such as higher protection against needlestick injuries and less risk of bacterial contamination. In addition, needleless connectors reduce the risk of Healthcare Associated Bloodstream Infections. Owing to these features, the demand for needleless connectors is predicted to augment over the forecast period.
Indication Insights:
Based on Indication, the U.S. home infusion therapy market is categorized into Anti-infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Parenteral Nutrition, Immunoglobulins, and Others. Hydration therapy provides several benefits, such as boosting immunity and reduced recovery time. It also improves cognitive functions, flushes toxins from the body, is efficient, it tends to strengthen joint, skin, and muscle health.
COVID-19 Impact on U.S. Home Infusion Therapy Market:
The COVID-19 pandemic has positively impacted the Industry. The U.S. Key players reported a significant growth in revenues from services, devices, and drugs, owing to the considerable increase in patients receiving infusion therapy at home during COVID-19 restrictions. For instance, Option Care Health, Inc. generated USD 3,302.6 million in 2020 and witnessed a 30.1% increase in its revenue in 2020 compared to 2019. The growth was attributable to increased demand for its home infusion therapy services.
Furthermore, In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule broadening coverage for home infusion Durable Medical Equipment (DME), specifically for external infusion pumps, to increase access to home infusion drugs. Moreover, with the COVID-19 outbreak, home-infusion solutions have become more critical than ever, allowing patients to remain in their homes, thereby decreasing the risk of exposure. Hence, various local infusion service providers witnessed a surge in demand for home-based services.
Key Players:
CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings are the leading competitors in the U.S. home infusion therapy market. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.
Renub Research latest report “U.S. Home Infusion Therapy Market, Forecast By Product (Home Infusion Device, Home Infusion Drugs, Home Infusion Services), Product Type (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Indication (Anti-infective, Chemotherapy, HydrationTherapy, EnteralNutrition, Parenteral Nutrition, Immunoglobulins, Others), Zone ( East North Central, West South Central, South Atlantica, North East, East South Central, West North Centre, Pacific Central, Mountain States,) Companies (CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, InfuSystems Holdings)” provides a detailed analysis of U.S. Home Infusion Therapy Industry.
Product – The market has been studied from 3 viewpoints:
1. Home Infusion Device
2. Home Infusion Drugs
3. Home Infusion Services
Product Type – The market has been studied from 4 viewpoints:
1. Infusion Pump
2. Intravenous Sets
3. IV Cannulas
4. Needleless Connectors
Indication – The market has been studied from 7 viewpoints:
1. Anti-infective
2. Chemotherapy
3. Hydration Therapy
4. Enteral Nutrition
5. Parenteral Nutrition
6. Immunoglobulins
7. Others
Zone – The market has been studied from 8 viewpoints:
1. East North Central
2. West South Central
3. South Atlantica
4. North East
5. East South Central
6. West North Centre
7. Pacific Central
8. Mountain States
Company Insights:
• Overview
• Initiatives/Recent Developments
• Financial Insight
Companies Covered:
1. CVS Health
2. Becton, Dickinson and Company
3. Smith & Nephew plc
4. Terumo Corporation
5. ICU Medical
6. Moog
7. InfuSystems Holdings
- 1. Introduction
- 2. Research & Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. United States Home Infusion Therapy Market
- 6. Market Share – United States Home Infusion Therapy Market
- 6.1 By Product
- 6.2 By Product Type
- 6.3 By Indication
- 6.4 By Zone
- 7. Product – United States Home Infusion Therapy Market
- 7.1 Home Infusion Device
- 7.2 Home Infusion Drugs
- 7.3 Home Infusion Services
- 8. Product Type – United States Home Infusion Therapy Market
- 8.1 Infusion Pump
- 8.2 Intravenous Sets
- 8.3 IV Cannulas
- 8.4 Needleless Connectors
- 9. Indication – United States Home Infusion Therapy Market
- 9.1 Anti-infective
- 9.2 Chemotherapy
- 9.3 Hydration Therapy
- 9.4 Enteral Nutrition
- 9.5 Parenteral Nutrition
- 9.6 Immunoglobulins
- 9.7 Others
- 10. Zone – United States Home Infusion Therapy Market
- 10.1 East North Central
- 10.2 West South Central
- 10.3 South Atlantica
- 10.4 North East
- 10.5 East South Central
- 10.6 West North Centre
- 10.7 Pacific Central
- 10.8 Mountain States
- 11. Key Players
- 11.1 CVS Health
- 11.1.1 Overview
- 11.1.2 Recent Development
- 11.1.3 Revenue
- 11.2 Becton, Dickinson and Company
- 11.2.1 Overview
- 11.2.2 Recent Development
- 11.2.3 Revenue
- 11.3 Smith & Nephew plc
- 11.3.1 Overview
- 11.3.2 Recent Development
- 11.3.3 Revenue
- 11.4 Terumo Corporation
- 11.4.1 Overview
- 11.4.2 Recent Development
- 11.4.3 Revenue
- 11.5 ICU Medical
- 11.5.1 Overview
- 11.5.2 Recent Development
- 11.5.3 Revenue
- 11.6 Moog
- 11.6.1 Overview
- 11.6.2 Recent Development
- 11.6.3 Revenue
- 11.7 InfuSystems Holdings
- 11.7.1 Overview
- 11.7.2 Recent Development
- 11.7.3 Revenue
- List of Figures:
- Figure-01: United States – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-02: United States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-03: Product – Home Infusion Device Market (Million US$), 2017 – 2022
- Figure-04: Product – Forecast for Home Infusion Device Market (Million US$), 2023 – 2027
- Figure-05: Product – Home Infusion Drugs Market (Million US$), 2017 – 2022
- Figure-06: Product – Forecast for Home Infusion Drugs Market (Million US$), 2023 – 2027
- Figure-07: Product – Home Infusion Services Market (Million US$), 2017 – 2022
- Figure-08: Product – Forecast for Home Infusion Services Market (Million US$), 2023 – 2027
- Figure-09: Product Type – Infusion Pump Market (Million US$), 2017 – 2022
- Figure-10: Product Type – Forecast for Infusion Pump Market (Million US$), 2023 – 2027
- Figure-11: Product Type – Intravenous Sets Market (Million US$), 2017 – 2022
- Figure-12: Product Type – Forecast for Intravenous Sets Market (Million US$), 2023 – 2027
- Figure-13: Product Type – IV Cannulas Market (Million US$), 2017 – 2022
- Figure-14: Product Type – Forecast for IV Cannulas Market (Million US$), 2023 – 2027
- Figure-15: Product Type – Needleless Connectors Market (Million US$), 2017 – 2022
- Figure-16: Product Type – Forecast for Needleless Connectors Market (Million US$), 2023 – 2027
- Figure-17: Indication – Anti-infective Market (Million US$), 2017 – 2022
- Figure-18: Indication – Forecast for Anti-infective Market (Million US$), 2023 – 2027
- Figure-19: Indication – Chemotherapy Market (Million US$), 2017 – 2022
- Figure-20: Indication – Forecast for Chemotherapy Market (Million US$), 2023 – 2027
- Figure-21: Indication – Hydration Therapy Market (Million US$), 2017 – 2022
- Figure-22: Indication – Forecast for Hydration Therapy Market (Million US$), 2023 – 2027
- Figure-23: Indication – Enteral Nutrition Market (Million US$), 2017 – 2022
- Figure-24: Indication – Forecast for Enteral Nutrition Market (Million US$), 2023 – 2027
- Figure-25: Indication – Parenteral Nutrition Market (Million US$), 2017 – 2022
- Figure-26: Indication – Forecast for Parenteral Nutrition Market (Million US$), 2023 – 2027
- Figure-27: Indication – Immunoglobulins Market (Million US$), 2017 – 2022
- Figure-28: Indication – Forecast for Immunoglobulins Market (Million US$), 2023 – 2027
- Figure-29: Indication – Others Market (Million US$), 2017 – 2022
- Figure-30: Indication – Forecast for Others Market (Million US$), 2023 – 2027
- Figure-31: East North Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-32: East North Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-33: West South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-34: West South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-35: South Atlantica – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-36: South Atlantica – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-37: North East – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-38: North East – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-39: East South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-40: East South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-41: West North Centre – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-42: West North Centre – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-43: Pacific Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-44: Pacific Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-45: Mountain States – Home Infusion Therapy Market (Million US$), 2017 – 2022
- Figure-46: Mountain States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
- Figure-47: CVS Health – Global Revenue (Million US$), 2017 – 2022
- Figure-48: CVS Health – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-49: Becton, Dickinson and Company – Global Revenue (Million US$), 2017 – 2022
- Figure-50: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-51: Smith & Nephew plc – Global Revenue (Million US$), 2017 – 2022
- Figure-52: Smith & Nephew plc – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-53: Terumo Corporation – Global Revenue (Million US$), 2017 – 2022
- Figure-54: Terumo Corporation – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-55: ICU Medical – Global Revenue (Million US$), 2017 – 2022
- Figure-56: ICU Medical – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-57: Moog – Global Revenue (Million US$), 2017 – 2022
- Figure-58: Moog – Forecast for Global Revenue (Million US$), 2023 – 2027
- Figure-59: InfuSystems Holdings – Global Revenue (Million US$), 2017 – 2022
- Figure-60: InfuSystems Holdings – Forecast for Global Revenue (Million US$), 2023 – 2027
- List of Tables:
- Table-01: United States – Home Infusion Therapy Market Share by Product (Percent), 2017 – 2022
- Table-02: United States – Forecast for Home Infusion Therapy Market Share by Product (Percent), 2023 – 2027
- Table-03: United States – Home Infusion Therapy Market Share by Product Type (Percent), 2017 – 2022
- Table-04: United States – Forecast for Home Infusion Therapy Market Share by Product Type (Percent), 2023 – 2027
- Table-05: United States – Home Infusion Therapy Market Share by Indication (Percent), 2017 – 2022
- Table-06: United States – Forecast for Home Infusion Therapy Market Share by Indication (Percent), 2023 – 2027
- Table-07: United States – Home Infusion Therapy Market Share by Zone (Percent), 2017 – 2022
- Table-08: United States – Forecast for Home Infusion Therapy Market Share by Zone (Percent), 2023 – 2027
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook